What is the share price of Mangalam Drugs and Organics Ltd (MANGALAM) today?
The share price of MANGALAM as on 15th September 2025 is ₹75.21. The stock prices are volatile and keep changing through the day depending upon various factors and market conditions.What is the return on Mangalam Drugs and Organics Ltd (MANGALAM) share?
The past returns of Mangalam Drugs and Organics Ltd (MANGALAM) share are- Past 1 week: -0.73%
- Past 1 month: -1.97%
- Past 3 months: -8.41%
- Past 6 months: -6.79%
- Past 1 year: -41.39%
- Past 3 years: -47.63%
- Past 5 years: -45.11%
What are the peers or stocks similar to Mangalam Drugs and Organics Ltd (MANGALAM)?
The peers or stocks similar to Mangalam Drugs and Organics Ltd (MANGALAM) include:What is the market cap of Mangalam Drugs and Organics Ltd (MANGALAM) share?
Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Mangalam Drugs and Organics Ltd (MANGALAM) is ₹119.11 Cr as of 15th September 2025.What is the 52 week high and low of Mangalam Drugs and Organics Ltd (MANGALAM) share?
The 52-week high of Mangalam Drugs and Organics Ltd (MANGALAM) is ₹140.50 and the 52-week low is ₹70.10.What is the PE and PB ratio of Mangalam Drugs and Organics Ltd (MANGALAM) stock?
The P/E (price-to-earnings) ratio of Mangalam Drugs and Organics Ltd (MANGALAM) is 17.72. The P/B (price-to-book) ratio is 0.88.Which sector does Mangalam Drugs and Organics Ltd (MANGALAM) belong to?
Mangalam Drugs and Organics Ltd (MANGALAM) belongs to the Health Care sector & Pharmaceuticals sub-sector.How to buy Mangalam Drugs and Organics Ltd (MANGALAM) shares?
You can directly buy Mangalam Drugs and Organics Ltd (MANGALAM) shares on Tickertape. Simply sign up, connect your demat account and place your order.
Mangalam Drugs and Organics Ltd
MANGALAM Share Price
75.210.05% (-0.04)
High
—
—
Low
—
—
Returns
—
—
1D
1W
1M
1Y
5Y
Max
SIP
1D
1W
1M
1Y
5Y
Max
SIP
MANGALAM Stock Scorecard
Performance
LowHasn't fared well - amongst the low performers
Valuation
HighSeems to be overvalued vs the market average
Growth
LowLagging behind the market in financials growth
Profitability
AvgAverage profitability - not good, not bad
Entry point
AvgThe stock is not in the overbought zone
Red flags
LowNo red flag found
How to use scorecard? Learn more
MANGALAM Performance & Key Metrics
MANGALAM Performance & Key Metrics
| No LabelNo Label | PB RatioPB Ratio | Dividend YieldDiv. Yield |
|---|---|---|
| -12.22 | 0.88 | — |
| Sector PESector PE | Sector PBSector PB | Sector Div YldSctr Div Yld |
|---|---|---|
| 37.36 | 5.90 | 0.58% |
MANGALAM Analyst Ratings & Forecast
—
Analyst Ratings data is currently unavailable for this stockPrice Upside
Earnings Growth
Rev. Growth
MANGALAM Company Profile
Mangalam Drugs and Organics Limited is engaged in the manufacturing of drugs, medicines and allied products. The Company also manufactures active pharma ingredients (API), intermediates and specialty chemicals.
SUNPHARMA
PE Ratio
35.49
35.49
1Y Return
13.34%
13.34%
Buy Reco %
86.11
86.11
CIPLA
PE Ratio
24.12
24.12
1Y Return
4.99%
4.99%
Buy Reco %
66.67
66.67
TORNTPHARM
PE Ratio
63.15
63.15
1Y Return
3.03%
3.03%
Buy Reco %
76.00
76.00
DRREDDY
PE Ratio
19.38
19.38
1Y Return
1.50%
1.50%
Buy Reco %
40.00
40.00
MANKIND
PE Ratio
53.48
53.48
1Y Return
6.10%
6.10%
Buy Reco %
81.25
81.25
MANGALAM Forecast
MANGALAM Forecasts
Forecast data is currently unavailable
Forecast data is currently unavailable
Price
Price Upside
Revenue
Revenue Growth
Earnings
Earnings Per Share
MANGALAM
MANGALAM
Income
Balance Sheet
Cash Flow
Annual Normal View
MANGALAM Income Statement
MANGALAM Income Statement
Annual Normal View
| Financial Year | FY 2024 | FY 2025 | TTM | |||
|---|---|---|---|---|---|---|
| Total Revenue | 368.69 | 318.73 | 299.53 | |||
Raw Materials | 235.41 | 282.41 | 275.89 | |||
| Power & Fuel Cost | 28.50 | |||||
| Employee Cost | 39.07 | |||||
| Selling & Administrative Expenses | 13.08 | |||||
| Operating & Other expenses | 35.14 | |||||
EBITDA | 17.49 | 36.32 | 23.64 | |||
| Depreciation/Amortization | 14.65 | 16.61 | 17.20 | |||
| PBIT | 2.84 | 19.71 | 6.44 | |||
| Interest & Other Items | 13.92 | 14.93 | 15.23 | |||
| PBT | -11.08 | 4.78 | -8.79 | |||
| Taxes & Other Items | -2.00 | -1.94 | 0.96 | |||
| Net Income | -9.08 | 6.72 | -9.75 | |||
| EPS | -5.74 | 4.25 | -6.16 | |||
| DPS | 0.00 | 0.00 | 0.00 | |||
| Payout ratio | 0.00 | 0.00 | 0.00 |
MANGALAM Company Updates
FY 2016FY 2016
Investor Presentation
May 24PDF
MANGALAM Stock Peers
MANGALAM Past Performance & Peer Comparison
MANGALAM Past Performance & Peer Comparison
Comparing 3 stocks from
Health CarePharmaceuticals
Compare valuation on Screener
Health CarePharmaceuticals
Valuation
Technical
Forecast
Compare valuation on Screener| Stock | PE RatioPE Ratio | PB RatioPB Ratio | Div. YieldDividend Yield |
|---|---|---|---|
| Mangalam Drugs and Organics Ltd | 17.72 | 0.88 | — |
| Sun Pharmaceutical Industries Ltd | 35.49 | 5.35 | 0.99% |
| Cipla Ltd | 24.12 | 4.06 | 1.02% |
| Torrent Pharmaceuticals Ltd | 63.15 | 15.90 | 0.90% |
MANGALAM Stock Price Comparison
Compare MANGALAM with any stock or ETFCompare MANGALAM with any stock or ETF
MANGALAM
MANGALAM Holdings
MANGALAM Shareholdings
MANGALAM Promoter Holdings Trend
MANGALAM Promoter Holdings Trend
MANGALAM Institutional Holdings Trend
MANGALAM Institutional Holdings Trend
Total Retail Holding
Increasing retail holding can be considered bad as it can reflect that institutions and promoters are selling their stake which is being absorbed by retail investors.
In last 3 months, retail holding in the company has almost stayed constant
Foreign Institutional Holding
Foreign Institutional Holding is quantum of stock held by foreign large-quantities-trading entities. Increasing value indicates growing support and comfort for the stock
In last 3 months, foreign institutional holding of the company has almost stayed constant
MANGALAM Shareholding Pattern
MANGALAM Shareholding Pattern
MANGALAM Shareholding History
MANGALAM Shareholding History
Foreign Institutions
Hmm, looks like there hasn't been any net deal activity in the last 6 monthssmallcases containing MANGALAM stock
smallcases containing MANGALAM stock
Looks like this stock is not in any smallcase yet.
MANGALAM Events
MANGALAM Events
MANGALAM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MANGALAM has not given any dividends in last 5 years
Dividends
Corp. Actions
Announcements
Legal Orders
Dividends
MANGALAM Dividend Trend
No Dividends
Dividends are the portion of earnings that a company distributes to all its shareholders every year
MANGALAM has not given any dividends in last 5 years
MANGALAM Upcoming Dividends
MANGALAM Upcoming Dividends
No upcoming dividends are available
MANGALAM Past Dividends
MANGALAM Past Dividends
Cash Dividend
Ex DateEx DateDec 21, 2017
Interim
Interim | Div/Share: ₹0.50
Dividend/Share
₹0.50
Ex DateEx Date
Dec 21, 2017
MANGALAM Stock News & Opinions
MANGALAM Stock News & Opinions
Articles & Videos
Corporate
Mangalam Drugs and Organics schedules AGM
Mangalam Drugs and Organics announced that the 52th Annual General Meeting(AGM) of the company will be held on 29 September 2025.Powered by Capital Market - Live
6 days agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to convene board meeting
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 5 September 2025.Powered by Capital Market - Live
2 weeks agoCapital Market - Live
Earnings
Mangalam Drugs and Organics reports consolidated net loss of Rs 13.80 crore in the June 2025 quarter
Net loss of Mangalam Drugs and Organics reported to Rs 13.80 crore in the quarter ended June 2025 as against net profit of Rs 2.68 crore during the previous quarter ended June 2024. Sales declined 25.21% to Rs 57.21 crore in the quarter ended June 2025 as against Rs 76.49 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales57.2176.49 -25 OPM %-7.8310.71 - PBDT-8.524.46 PL PBT-13.000.58 PL NP-13.802.68 PL Powered by Capital Market - Live
1 month agoCapital Market - Live
Earnings
Mangalam Drugs and Organics reports standalone net loss of Rs 13.73 crore in the June 2025 quarter
Net loss of Mangalam Drugs and Organics reported to Rs 13.73 crore in the quarter ended June 2025 as against net profit of Rs 2.68 crore during the previous quarter ended June 2024. Sales declined 25.21% to Rs 57.21 crore in the quarter ended June 2025 as against Rs 76.49 crore during the previous quarter ended June 2024. ParticularsQuarter EndedJun. 2025Jun. 2024% Var. Sales57.2176.49 -25 OPM %-7.8810.69 - PBDT-8.554.45 PL PBT-12.930.58 PL NP-13.732.68 PL Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to hold board meeting
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 7 August 2025.Powered by Capital Market - Live
1 month agoCapital Market - Live
Corporate
Mangalam Drugs and Organics schedules EGM
Mangalam Drugs and Organics announced that an Extra Ordinary General Meeting (EGM) of the Company will be held on 12 August 2025.Powered by Capital Market - Live
2 months agoCapital Market - Live
Earnings
Mangalam Drugs and Organics consolidated net profit declines 98.30% in the March 2025 quarter
Net profit of Mangalam Drugs and Organics declined 98.30% to Rs 0.06 crore in the quarter ended March 2025 as against Rs 3.53 crore during the previous quarter ended March 2024. Sales declined 28.61% to Rs 72.78 crore in the quarter ended March 2025 as against Rs 101.94 crore during the previous quarter ended March 2024. For the full year,net profit reported to Rs 6.72 crore in the year ended March 2025 as against net loss of Rs 9.07 crore during the previous year ended March 2024. Sales declined 13.55% to Rs 317.58 crore in the year ended March 2025 as against Rs 367.35 crore during the previous year ended March 2024. ParticularsQuarter EndedYear EndedMar. 2025Mar. 2024% Var.Mar. 2025Mar. 2024% Var. Sales72.78101.94 -29 317.58367.35 -14 OPM %13.9611.47 -11.284.73 - PBDT6.347.79 -19 21.393.58 497 PBT1.633.93 -59 4.79-11.07 LP NP0.063.53 -98 6.72-9.07 LP Powered by Capital Market - Live
3 months agoCapital Market - Live
Corporate
Mangalam Drugs and Organics announces board meeting date
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 17 May 2025.Powered by Capital Market - Live
4 months agoCapital Market - Live
Corporate
Mangalam Drugs and Organics to conduct board meeting
Mangalam Drugs and Organics will hold a meeting of the Board of Directors of the Company on 11 April 2025.Powered by Capital Market - Live
5 months agoCapital Market - Live
Earnings
Mangalam Drugs and Organics standalone net profit rises 180.00% in the December 2024 quarter
Net profit of Mangalam Drugs and Organics rose 180.00% to Rs 1.40 crore in the quarter ended December 2024 as against Rs 0.50 crore during the previous quarter ended December 2023. Sales declined 8.76% to Rs 88.55 crore in the quarter ended December 2024 as against Rs 97.05 crore during the previous quarter ended December 2023. ParticularsQuarter EndedDec. 2024Dec. 2023% Var. Sales88.5597.05 -9 OPM %9.907.18 - PBDT5.413.66 48 PBT1.480.04 3600 NP1.400.50 180 Powered by Capital Market - Live
6 months agoCapital Market - Live
In last 6 months, promoter holding in the company has almost stayed constant
Pledged promoter holdings is insignificant